Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 01/22/2024
UPDATED: 01/22/2024
DUE: 06/22/2026
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable...
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 01/22/2024
UPDATED: 01/22/2024
DUE: 01/07/2027
The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-1...
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
HHS-NIH11
POSTED: 01/22/2024
UPDATED: 01/22/2024
DUE: 03/09/2026
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recen...
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
HHS-NIH11
POSTED: 01/18/2024
UPDATED: 01/18/2024
DUE: 03/09/2026
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recen...
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
HHS-NIH11
POSTED: 01/17/2024
UPDATED: 01/17/2024
DUE: 02/11/2027
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the pot...
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 01/15/2025
UPDATED: 01/15/2025
DUE: 03/08/2026
This Notice of Funding Opportunity (NOFO) invites applications for studies of type 1 diabetes etiology and pathogenesis using data and samples from clinical trials and studies. This opportunity is int...
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
HHS-NIH11
POSTED: 01/15/2025
UPDATED: 01/15/2025
DUE: 10/25/2027
Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimula...
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
HHS-NIH11
POSTED: 01/15/2025
UPDATED: 01/15/2025
DUE: 10/25/2027
Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based ...
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
HHS-NIH11
POSTED: 01/14/2025
UPDATED: 01/14/2025
DUE: 10/14/2027
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from m...
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
HHS-NIH11
POSTED: 01/13/2025
UPDATED: 01/13/2025
DUE: 05/07/2027
The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative and interdisciplinary research teams focused on clinical, health services, and/or community-based interventions that a...